greeksoup/ stock research

Balchem (BCPC) Q3 FY2024 earnings: revenue $240 million, up 4.3% on the year

Balchem Corp. (BCPC) reported revenue of $240 million for Q3 FY2024, the quarter ended 30 September 2024, up 4.3% on the same quarter a year earlier. Net income was $34 million, up 16.4% on the year, and diluted earnings per share $1.03. The figures are the company's own, from the 10-Q it filed with the SEC on 25 October 2024.

Revenue$240 millionup 4.3%
Net income$34 millionup 16.4%
Diluted EPS$1.03
QuarterQ3 FY2024ended 30 September 2024

The quarter, against the one before and a year earlier

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Revenue240234230+4.3%
Cost of revenue155151153+0.8%
Gross profit85.483.076.5+11.5%
Gross margin35.6%35.5%33.3%
Research and development4.33.93.9+11.9%
Operating income48.045.843.6+10.0%
Operating margin20.0%19.6%19.0%
Pre-tax income43.941.236.5+20.3%
Income tax10.19.27.4+35.9%
Effective tax rate22.9%22.2%20.3%
Net income33.832.129.1+16.4%
Net margin14.1%13.7%12.6%
Diluted EPS$1.03$0.98$0.90+14.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Operating cash flow51.345.046.5+10.3%
Capital expendituren/an/a8.3n/a
Free cash flown/an/a38.2n/a
Free cash flow marginn/an/a16.6%
Cash from investing-9.2-6.9-9.3n/a
Cash from financing-34.4-34.2-25.1n/a
Depreciation and amortisation10.912.513.8-21.0%
Share-based compensation4.23.93.7+10.7%
Buybacks0.20.00.1+61.4%
Dividends paid0.00.00.0+33.3%
Diluted shares, weighted33m33m32m+0.9%
Shares outstanding at period end33m32m32m+0.8%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ3 FY2024Q2 FY2024Q3 FY2023Change on the year
Shareholders' equity1,1771,1121,025+14.8%
Debt245284396-38.1%
Operating lease liabilities13.113.713.2-1.2%
Finance lease liabilities1.81.82.0-9.9%
Other liabilities160163167-4.3%
Total liabilities and equity1,5971,5751,603-0.4%
Fixed assets277273269+3.2%
Goodwill781770767+1.9%
Intangible assets178176192-7.6%
Cash and equivalents73.763.777.0-4.2%
Receivables121123129-6.6%
Inventory119117116+1.9%
Other assets48.152.153.6-10.2%
Total assets1,5971,5751,603-0.4%

Questions

What was Balchem's revenue in Q3 FY2024?

Balchem (BCPC) reported revenue of $240 million for Q3 FY2024, the quarter ended 30 September 2024, up 4.3% on the same quarter a year earlier.

How much did Balchem earn in Q3 FY2024?

Net income for Q3 FY2024 was $34 million, up 16.4% on the year, and diluted earnings per share $1.03.

When did Balchem report Q3 FY2024 results?

Balchem filed its 10-Q for the quarter ended 30 September 2024 with the SEC on 25 October 2024.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Revenue230229240234240240251255268264271284
Cost of revenue153154158151155154162162172170170180
Gross profit76.575.081.583.085.486.388.293.195.593.9101104
Gross margin33%33%34%35%36%36%35%36%36%36%37%37%
R&D3.93.94.13.94.34.54.74.34.55.15.94.5
Operating income43.638.341.745.848.047.451.051.454.652.355.659.2
Operating margin19%17%17%20%20%20%20%20%20%20%21%21%
Pre-tax income36.533.336.941.243.944.547.949.052.050.052.557.8
Tax rate20%20%21%22%23%25%23%22%23%22%23%23%
Net income29.126.629.032.133.833.637.138.340.339.240.344.6
Net margin13%12%12%14%14%14%15%15%15%15%15%16%
Diluted EPS$0.90$0.82$0.89$0.98$1.03$1.03$1.13$1.17$1.24$1.21$1.25$1.39
Operating cash flow46.567.433.445.051.352.336.547.365.667.340.146.7
Capital expenditure8.3n/an/an/an/an/an/an/an/an/an/an/a
Free cash flow38.2n/an/an/an/an/an/an/an/an/an/an/a
Buybacks0.10.45.20.00.20.35.333.315.453.615.728.8
Dividends paid0.00.025.60.00.00.028.30.00.00.030.80.0
Shares outstanding32m32m32m32m33m33m33m32m32m32m32m32m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read moreMoney is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2024, filed 25 October 2024, accession 0001628280-24-043795: the filing on EDGAR. All of Balchem Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install